Growth Hormone Secretagogue Receptor Agonist [EPC] - N0000193785

Name: Table of NDC products with growth hormone secretagogue receptor agonist
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193785
Pharmacologic Name	Growth Hormone Secretagogue Receptor Agonist
Pharmacologic Uses	growth hormone (GH) secretagogue receptor agonist
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Growth Hormone Secretagogue Receptor Agonist

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Growth Hormone Secretagogue Receptor Agonist [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0169-1401	Macrilen	Non-Proprietary Name: Macimorelin Acetate	Granule, For Solution	Oral	Novo Nordisk	ACTIVE
	71090-002	Macrilen	Non-Proprietary Name: Macimorelin Acetate	Granule, For Solution	Oral	Strongbridge U.s. Inc	ACTIVE